Vascular endothelial function in health and diseases
Tóm tắt
Từ khóa
Tài liệu tham khảo
Irie, 1991, Transendothelial transport of macromolecules: the concept of tissue-blood barriers, Cell Biol. Rev., 25, 317
Herrmann, 2001, The endothelium: dysfunction and beyond, J. Nucl. Cardiol., 8, 197, 10.1067/mnc.2001.114148
Furchgott, 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, 373, 10.1038/288373a0
Widlansky, 2003, The clinical implications of endothelial dysfunction, J. Am. Coll. Cardiol., 42, 1149, 10.1016/S0735-1097(03)00994-X
Laroia, 2003, Endothelium and the lipid metabolism: the current understanding, Int. J. Cardiol., 88, 1, 10.1016/S0167-5273(02)00366-2
Vanhoutte, 2004, Endothelium-dependent hyperpolarizations: the history, Pharmacol. Res., 49, 503, 10.1016/j.phrs.2003.11.015
Vane, 2003, Prostacyclin: a vascular mediator, Eur. J. Vasc. Endovasc. Surg., 26, 571, 10.1016/S1078-5884(03)00385-X
Parkington, 2004, Prostacyclin and endothelium-dependent hyperpolarization, Pharmacol. Res., 49, 509, 10.1016/j.phrs.2003.11.012
McGuire, 2001, Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s), Can. J. Physiol. Pharmacol., 79, 443, 10.1139/y01-025
Moncada, 1991, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev., 43, 109
Behrendt, 2002, Endothelial function. From vascular biology to clinical applications, Am. J. Cardiol., 90, 40L, 10.1016/S0002-9149(02)02963-6
Palmer, 1988, Vascular endothelial cells synthesize nitric oxide from l-arginine, Nature, 333, 664, 10.1038/333664a0
Forstermann, 2006, Endothelial nitric oxide synthase in vascular disease: from marvel to menace, Circulation, 113, 1708, 10.1161/CIRCULATIONAHA.105.602532
Vanhoutte, 2003, Endothelial control of vasomotor function: from health to coronary disease, Circ. J., 67, 572, 10.1253/circj.67.572
Pohl, 1986, Crucial role of endothelium in the vasodilator response to increased flow in vivo, Hypertension, 8, 37, 10.1161/01.HYP.8.1.37
Celermajer, 1997, Endothelial dysfunction: does it matter? Is it reversible?, J. Am. Coll. Cardiol., 30, 325, 10.1016/S0735-1097(97)00189-7
Dimmeler, 1999, Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, 399, 601, 10.1038/21224
Al Sa’doni, 2000, S-Nitrosothiols: a class of nitric oxide-donor drugs, Clin. Sci. (Lond.), 98, 507, 10.1042/CS19990267
Lincoln, 1994, Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase, Hypertension, 23, 1141, 10.1161/01.HYP.23.6.1141
Pfeifer, 1998, Defective smooth muscle regulation in cGMP kinase I-deficient mice, EMBO J., 17, 3045, 10.1093/emboj/17.11.3045
Massberg, 1999, Increased adhesion and aggregation of platelets lacking cyclic guanosine 3’,5’-monophosphate kinase I, J. Exp. Med., 189, 1255, 10.1084/jem.189.8.1255
Gross, 1995, Nitric oxide: pathophysiological mechanisms, Annu. Rev. Physiol., 57, 737, 10.1146/annurev.ph.57.030195.003513
Mendelsohn, 1990, Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine, J. Biol. Chem., 265, 19028, 10.1016/S0021-9258(17)30619-1
Kubes, 1991, Nitric oxide: an endogenous modulator of leukocyte adhesion, Proc. Natl. Acad. Sci. U.S.A., 88, 4651, 10.1073/pnas.88.11.4651
Marks, 1995, Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide, J. Clin. Invest., 96, 2630, 10.1172/JCI118328
Garg, 1989, Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells, J. Clin. Invest., 83, 1774, 10.1172/JCI114081
Stankevicius, 2003, Role of nitric oxide and other endothelium-derived factors, Medicina (Kaunas.), 39, 333
Gryglewski, 1983, Prostacyclin—experimental and clinical approach, Adv. Prostaglandin Thromboxane Leukot. Res., 11, 457
Gryglewski, 1979, Prostacyclin as a circulatory hormone, Biochem. Pharmacol., 28, 3161, 10.1016/0006-2952(79)90055-8
Chang, 1987, Phospholipase A2: function and pharmacological regulation, Biochem. Pharmacol., 36, 2429, 10.1016/0006-2952(87)90512-0
Coleman, 1994, International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes, Pharmacol. Rev., 46, 205
Radomski, 1987, The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide, Br. J. Pharmacol., 92, 639, 10.1111/j.1476-5381.1987.tb11367.x
Taylor, 1988, Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium, Trends Pharmacol. Sci., 9, 272, 10.1016/0165-6147(88)90003-X
Edwards, 2001, EDHF—are there gaps in the pathway?, J. Physiol., 531, 299, 10.1111/j.1469-7793.2001.0299i.x
Triggle, 1999, Endothelium-derived hyperpolarizing factor(s): species and tissue heterogeneity, Clin. Exp. Pharmacol. Physiol., 26, 176, 10.1046/j.1440-1681.1999.03007.x
Nelson, 1990, Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels, Nature, 344, 770, 10.1038/344770a0
Quilley, 2000, Is EDHF an epoxyeicosatrienoic acid?, Trends Pharmacol. Sci., 21, 121, 10.1016/S0165-6147(00)01445-0
Matoba, 2000, Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice, J. Clin. Invest., 106, 1521, 10.1172/JCI10506
Hamilton, 2001, Is hydrogen peroxide an EDHF in human radial arteries?, Am. J. Physiol. Heart Circ. Physiol., 280, H2451, 10.1152/ajpheart.2001.280.6.H2451
Fisslthaler, 1999, Cytochrome P450 2C is an EDHF synthase in coronary arteries, Nature, 401, 493, 10.1038/46816
Coats, 2001, Endothelium-derived hyperpolarizing factor: identification and mechanisms of action in human subcutaneous resistance arteries, Circulation, 103, 1702, 10.1161/01.CIR.103.12.1702
Nithipatikom, 2000, Determination of EETs using microbore liquid chromatography with fluorescence detection, Am. J. Physiol. Heart Circ. Physiol., 279, H857, 10.1152/ajpheart.2000.279.2.H857
Pratt, 2001, Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs, Am. J. Physiol. Heart Circ. Physiol., 280, H1113, 10.1152/ajpheart.2001.280.3.H1113
Griffith, 2004, Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?, Br. J. Pharmacol., 141, 881, 10.1038/sj.bjp.0705698
Emerson, 2000, Electrical coupling between endothelial cells and smooth muscle cells in hamster feed arteries: role in vasomotor control, Circ. Res., 87, 474, 10.1161/01.RES.87.6.474
Emerson, 2001, Electrical activation of endothelium evokes vasodilation and hyperpolarization along hamster feed arteries, Am. J. Physiol. Heart Circ. Physiol., 280, H160, 10.1152/ajpheart.2001.280.1.H160
de Wit, 2000, Impaired conduction of vasodilation along arterioles in connexin40-deficient mice, Circ. Res., 86, 649, 10.1161/01.RES.86.6.649
Christ, 1996, Gap junctions in vascular tissues. Evaluating the role of intercellular communication in the modulation of vasomotor tone, Circ. Res., 79, 631, 10.1161/01.RES.79.4.631
Daut, 1994, The role of the membrane potential of endothelial and smooth muscle cells in the regulation of coronary blood flow, J. Cardiovasc. Electrophysiol., 5, 154, 10.1111/j.1540-8167.1994.tb01156.x
Inoue, 1991, Expression of a hybrid Cu/Zn-type superoxide dismutase which has high affinity for heparin-like proteoglycans on vascular endothelial cells, J. Biol. Chem., 266, 16409, 10.1016/S0021-9258(18)55313-8
Beckman, 1990, Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci. U.S.A., 87, 1620, 10.1073/pnas.87.4.1620
Wei, 1996, Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite, Am. J. Physiol., 271, H1262
Barlow, 2000, H(2)O(2) opens BK(Ca) channels via the PLA(2)-arachidonic acid signaling cascade in coronary artery smooth muscle, Am. J. Physiol. Heart Circ. Physiol., 279, H475, 10.1152/ajpheart.2000.279.2.H475
Ellis, 2003, Endothelium-derived reactive oxygen species: their relationship to endothelium-dependent hyperpolarization and vascular tone, Can. J. Physiol. Pharmacol., 81, 1013, 10.1139/y03-106
Kimura, 1992, Cytosolic calcium increase in coronary endothelial cells after H2O2 exposure and the inhibitory effect of U78517F, Br. J. Pharmacol., 107, 488, 10.1111/j.1476-5381.1992.tb12772.x
Barlow, 1998, Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity, Am. J. Physiol., 275, H1283
Edwards, 1998, K+ is an endothelium-derived hyperpolarizing factor in rat arteries, Nature, 396, 269, 10.1038/24388
De Mey, 1980, Interaction between Na+, K+ exchanges and the direct inhibitory effect of acetylcholine on canine femoral arteries, Circ. Res., 46, 826, 10.1161/01.RES.46.6.826
Fleming, 1980, The electrogenic Na+, K+-pump in smooth muscle: physiologic and pharmacologic significance, Annu. Rev. Pharmacol. Toxicol., 20, 129, 10.1146/annurev.pa.20.040180.001021
Knot, 1996, Extracellular K(+)-induced hyperpolarizations and dilatations of rat coronary and cerebral arteries involve inward rectifier K(+) channels, J. Physiol., 492, 419, 10.1113/jphysiol.1996.sp021318
Emerson, 2000, Endothelial cell pathway for conduction of hyperpolarization and vasodilation along hamster feed artery, Circ. Res., 86, 94, 10.1161/01.RES.86.1.94
Sandow, 2000, Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses, Circ. Res., 86, 341, 10.1161/01.RES.86.3.341
Dora, 2001, Properties of smooth muscle hyperpolarization and relaxation to K+ in the rat isolated mesenteric artery, Am. J. Physiol. Heart Circ. Physiol., 280, H2424, 10.1152/ajpheart.2001.280.6.H2424
Inoue, 1989, The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes, Proc. Natl. Acad. Sci. U.S.A., 86, 2863, 10.1073/pnas.86.8.2863
Brown, 2000, Functional significance of the isoforms of endothelin-converting enzyme-1, J. Cardiovasc. Pharmacol., 36, S26, 10.1097/00005344-200036051-00010
Anggard, 1989, The fate of radioiodinated endothelin-1 and endothelin-3 in the rat, J. Cardiovasc. Pharmacol., 13, S46, 10.1097/00005344-198900135-00012
Boulanger, 1990, Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide, J. Clin. Invest., 85, 587, 10.1172/JCI114477
Cines, 1998, Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood, 91, 3527
Kiely, 1997, Cardiopulmonary effects of endothelin-1 in man, Cardiovasc. Res., 33, 378, 10.1016/S0008-6363(96)00219-2
Pernow, 1996, Comparable potent coronary constrictor effects of endothelin-1 and big endothelin-1 in humans, Circulation, 94, 2077, 10.1161/01.CIR.94.9.2077
Molnar, 1995, Signal transduction in rat myometrial cells: comparison of the actions of endothelin-1, oxytocin and prostaglandin F2 alpha, Eur. J. Endocrinol., 133, 467, 10.1530/eje.0.1330467
Giardina, 2001, Role of endothelin B receptors in enhancing endothelium-dependent nitric oxide-mediated vascular relaxation during high salt diet, Hypertension, 37, 516, 10.1161/01.HYP.37.2.516
Halushka, 1989, Thromboxane, prostaglandin and leukotriene receptors, Annu. Rev. Pharmacol. Toxicol., 29, 213, 10.1146/annurev.pa.29.040189.001241
Smith, 1994, Characterization of dilator prostanoid receptors in the fetal rabbit ductus arteriosus, J. Pharmacol. Exp. Ther., 271, 390
McGiff, 1999, 20-HETE and the kidney: resolution of old problems and new beginnings, Am. J. Physiol., 277, R607
Makita, 1996, Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system, FASEB J., 10, 1456, 10.1096/fasebj.10.13.8940291
McGiff, 2001, 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure, Curr. Opin. Nephrol. Hypertens., 10, 231, 10.1097/00041552-200103000-00012
Gebremedhin, 2000, Production of 20-HETE and its role in autoregulation of cerebral blood flow, Circ. Res., 87, 60, 10.1161/01.RES.87.1.60
Zou, 1994, Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow, Am. J. Physiol., 266, F275
Marcum, 1984, Anticoagulantly active heparin-like molecules from vascular tissue, Biochemistry, 23, 1730, 10.1021/bi00303a023
Tollefsen, 1985, Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure, Blood, 66, 769, 10.1182/blood.V66.4.769.769
Esmon, 2000, Regulation of blood coagulation, Biochim. Biophys. Acta, 1477, 349, 10.1016/S0167-4838(99)00266-6
van, 2001, The endothelium: vascular control of haemostasis, Eur. J. Obstet. Gynecol. Reprod. Biol., 95, 198, 10.1016/S0301-2115(00)00490-5
Carmeliet, 1999, Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis, Cell, 98, 147, 10.1016/S0092-8674(00)81010-7
Ishii, 2001, Recombinant annexin II modulates impaired fibrinolytic activity in vitro and in rat carotid artery, Circ. Res., 89, 1240, 10.1161/hh2401.101066
Lingen, 2001, Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing, Arch. Pathol. Lab. Med., 125, 67, 10.5858/2001-125-0067-ROLAEC
Szekanecz, 1998, Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance, J. Investig. Med., 46, 27
Szekanecz, 2001, Chemokines and angiogenesis, Curr. Opin. Rheumatol., 13, 202, 10.1097/00002281-200105000-00009
Plow, 1995, The cell biology of the plasminogen system, FASEB J., 9, 939, 10.1096/fasebj.9.10.7615163
Koch, 1998, Review: angiogenesis: implications for rheumatoid arthritis, Arthritis Rheum., 41, 951, 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D
Dejana, 1996, Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis, J. Clin. Invest., 98, 1949, 10.1172/JCI118997
Leahy, 2000, Role of cyclooxygenases in angiogenesis, Curr. Med. Chem., 7, 1163, 10.2174/0929867003374336
Carlos, 1994, Leukocyte-endothelial adhesion molecules, Blood, 84, 2068, 10.1182/blood.V84.7.2068.2068
Szekanecz, 1992, Cell surface adhesion molecules: structure, function, clinical aspects, Orv. Hetil., 133, 135
Albelda, 1990, Integrins and other cell adhesion molecules, FASEB J., 4, 2868, 10.1096/fasebj.4.11.2199285
Varani, 1989, Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases, Am. J. Pathol., 135, 435
Irie, 1991, Transendothelial transport of macromolecules: the concept of tissue-blood barriers, Cell Biol. Rev., 25
Toborek, 1999, Endothelial cell functions. Relationship to atherogenesis, Basic Res. Cardiol., 94, 295, 10.1007/s003950050156
Pierangeli, 2001, Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin, Circ. Res., 88, 245, 10.1161/01.RES.88.2.245
Bordron, 1998, The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis, J. Clin. Invest., 101, 2029, 10.1172/JCI2261
Khazaei, 2004, Coronary vascular and aortic endothelial permeability during estrogen therapy: a study in DOCA-salt hypertensive ovariectomized rats, Physiol. Res., 53, 609
Lum, 1994, Regulation of vascular endothelial barrier function, Am. J. Physiol., 267, L223
Lum, 1996, Mechanisms of increased endothelial permeability, Can. J. Physiol. Pharmacol., 74, 787, 10.1139/y96-081
Ross, 1999, Atherosclerosis is an inflammatory disease, Am. Heart J., 138, S419, 10.1016/S0002-8703(99)70266-8
Schiffrin, 2000, Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan, Circulation, 101, 1653, 10.1161/01.CIR.101.14.1653
Park, 2001, Correlation of endothelial function in large and small arteries in human essential hypertension, J. Hypertens., 19, 415, 10.1097/00004872-200103000-00009
Park, 2001, Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension, J. Hypertens., 19, 921, 10.1097/00004872-200105000-00013
Panza, 1990, Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension, N. Engl. J. Med., 323, 22, 10.1056/NEJM199007053230105
Moncada, 1978, Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin, Pharmacol. Rev., 30, 293
Panza, 1993, Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension, J. Am. Coll. Cardiol., 21, 1145, 10.1016/0735-1097(93)90238-V
Schiffrin, 2002, Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function, J. Hypertens., 20, 71, 10.1097/00004872-200201000-00011
Taddei, 1996, Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients, Circulation, 94, 1298, 10.1161/01.CIR.94.6.1298
Taddei, 1998, Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension, Circulation, 97, 2222, 10.1161/01.CIR.97.22.2222
Chen, 2001, Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR, Hypertension, 38, 606, 10.1161/hy09t1.094005
Touyz, 2002, Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II, Circ. Res., 90, 1205, 10.1161/01.RES.0000020404.01971.2F
Schiffrin, 2003, Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade, J. Am. Coll. Cardiol., 42, 911, 10.1016/S0735-1097(03)00845-3
Lockette, 1986, The loss of endothelium-dependent vascular relaxation in hypertension, Hypertension, 8, II61, 10.1161/01.HYP.8.6_Pt_2.II61
Yoshibayashi, 1991, Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation, Circulation, 84, 2280, 10.1161/01.CIR.84.6.2280
Channick, 2004, Endothelin receptor antagonists in pulmonary arterial hypertension, J. Am. Coll. Cardiol., 43, 62S, 10.1016/j.jacc.2004.02.042
Landmesser, 2004, Endothelial function: a critical determinant in atherosclerosis?, Circulation, 109, II27, 10.1161/01.CIR.0000129501.88485.1f
Landmesser, 2001, Oxidant stress as a marker for cardiovascular events: Ox marks the spot, Circulation, 104, 2638, 10.1161/circ.104.22.2638
Cai, 2000, Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress, Circ. Res., 87, 840, 10.1161/01.RES.87.10.840
Landmesser, 2003, Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension, J. Clin. Invest., 111, 1201, 10.1172/JCI200314172
Laursen, 2001, Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin, Circulation, 103, 1282, 10.1161/01.CIR.103.9.1282
Tiefenbacher, 2000, Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis, Circulation, 102, 2172, 10.1161/01.CIR.102.18.2172
Vasquez-Vivar, 2002, Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants, Arterioscler. Thromb. Vasc. Biol., 22, 1655, 10.1161/01.ATV.0000029122.79665.D9
Spiekermann, 2003, Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation, Circulation, 107, 1383, 10.1161/01.CIR.0000056762.69302.46
Berry, 2000, Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries, Circulation, 101, 2206, 10.1161/01.CIR.101.18.2206
White, 1996, Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits, Proc. Natl. Acad. Sci. U.S.A., 93, 8745, 10.1073/pnas.93.16.8745
Landmesser, 2000, Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation, Circulation, 101, 2264, 10.1161/01.CIR.101.19.2264
Maier, 2000, Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease, J. Cardiovasc. Pharmacol., 35, 173, 10.1097/00005344-200002000-00001
Pasceri, 2000, Direct proinflammatory effect of C-reactive protein on human endothelial cells, Circulation, 102, 2165, 10.1161/01.CIR.102.18.2165
Eizawa, 1995, Lysophosphatidylcholine inhibits endothelium-dependent hyperpolarization and N omega-nitro-l-arginine/indomethacin-resistant endothelium-dependent relaxation in the porcine coronary artery, Circulation, 92, 3520, 10.1161/01.CIR.92.12.3520
Vidal, 1998, Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells, Eur. J. Biochem., 252, 378, 10.1046/j.1432-1327.1998.2520378.x
Chan, 2003, Oxidized low-density lipoprotein inhibits endothelium-dependent vasodilation by an antioxidant-sensitive, lysophosphatidylcholine-independent mechanism, J. Cardiovasc. Pharmacol., 41, 856, 10.1097/00005344-200306000-00005
Cunningham, 1997, Endothelin-1 and endothelin-4 stimulate monocyte production of cytokines, Crit. Care Med., 25, 958, 10.1097/00003246-199706000-00011
Kojima, 1996, Endothelin-1 has a priming effect on production of superoxide anion by alveolar macrophages: its possible correlation with bronchopulmonary dysplasia, Pediatr. Res., 39, 112, 10.1203/00006450-199601000-00016
Best, 2000, Endothelin in cardiovascular disease: from atherosclerosis to heart failure, J. Cardiovasc. Pharmacol., 35, S61, 10.1097/00005344-200000002-00014
Halim, 1995, Endothelin-1 evoked an increase and oscillations in cytosolic calcium concentration in adherent single human platelets and increased GMP-140 (P-selectin) in platelet suspension, Thromb. Res., 80, 105, 10.1016/0049-3848(95)00156-L
Petersen, 2002, Coronary artery myogenic response in a genetic model of hypertrophic cardiomyopathy, Am. J. Physiol. Heart Circ. Physiol., 283, H2244, 10.1152/ajpheart.00606.2002
Krams, 1998, Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation, Circulation, 97, 230, 10.1161/01.CIR.97.3.230
Maron, 1986, Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy, J. Am. Coll. Cardiol., 8, 545, 10.1016/S0735-1097(86)80181-4
Maron, 1996, Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles, JAMA, 276, 199, 10.1001/jama.1996.03540030033028
Tanaka, 1987, Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy, Circulation, 75, 1130, 10.1161/01.CIR.75.6.1130
Suzuki, 1995, Ultrastructural changes of blood capillaries in patients with microvascular angina, hypertrophic cardiomyopathy, and dilated cardiomyopathy, Am. J. Cardiovasc. Pathol., 5, 19
McBride, 1992, The health consequences of smoking. Cardiovascular diseases, Med. Clin. North Am., 76, 333, 10.1016/S0025-7125(16)30356-X
Poredos, 1999, Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction, Angiology, 50, 201, 10.1177/000331979905000304
Ueda, 2000, Tetrahydrobiopterin restores endothelial function in long-term smokers, J. Am. Coll. Cardiol., 35, 71, 10.1016/S0735-1097(99)00523-9
Campisi, 1999, l-Arginine normalizes coronary vasomotion in long-term smokers, Circulation, 99, 491, 10.1161/01.CIR.99.4.491
Sumida, 1998, Does passive smoking impair endothelium-dependent coronary artery dilation in women?, J. Am. Coll. Cardiol., 31, 811, 10.1016/S0735-1097(98)00010-2
Campisi, 1998, Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity, Circulation, 98, 119, 10.1161/01.CIR.98.2.119
Higman, 1996, Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein, Arterioscler. Thromb. Vasc. Biol., 16, 546, 10.1161/01.ATV.16.4.546
Nene, 1997, Cigarette smoking increases endothelial-derived vasorelaxation in the rat carotid artery in a dose-dependent manner, J. Surg. Res., 71, 101, 10.1006/jsre.1997.5147
Ota, 1997, Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract-role of free radicals and attenuation by captopril, Atherosclerosis, 131, 195, 10.1016/S0021-9150(97)06106-6
Mayhan, 1997, Effect of nicotine on endothelium-dependent arteriolar dilatation in vivo, Am. J. Physiol., 272, H2337
Mayhan, 1999, Acute infusion of nicotine potentiates norepinephrine-induced vasoconstriction in the hamster cheek pouch, J. Lab. Clin. Med., 133, 48, 10.1053/lc.1999.v133.a94238
Zeiher, 1995, Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function, Circulation, 92, 1094, 10.1161/01.CIR.92.5.1094
Czernin, 2003, Cigarette smoking and coronary blood flow, Prog. Cardiovasc. Dis., 45, 395, 10.1016/S0033-0620(03)80003-8
Taylor, 1998, Clinical and pathophysiological effects of active and passive smoking on the cardiovascular system, Can. J. Cardiol., 14, 1129
Iida, 1998, Mechanisms underlying cerebrovascular effects of cigarette smoking in rats in vivo, Stroke, 29, 1656, 10.1161/01.STR.29.8.1656
Wright, 2001, Effect of ECE and NEP inhibition on cigarette smoke-induced cell proliferation in the rat lung, Inhal. Toxicol., 13, 497, 10.1080/08958370151131873
McCusker, 1990, Selective increase of antioxidant enzyme activity in the alveolar macrophages from cigarette smokers and smoke-exposed hamsters, Am. Rev. Respir. Dis., 141, 678, 10.1164/ajrccm/141.3.678
Cerami, 1997, Tobacco smoke is a source of toxic reactive glycation products, Proc. Natl. Acad. Sci. U.S.A., 94, 13915, 10.1073/pnas.94.25.13915
Wang, 2001, Cigarette smoke activates caspase-3 to induce apoptosis of human umbilical venous endothelial cells, Mol. Genet. Metab., 72, 82, 10.1006/mgme.2000.3115
Aoshiba, 2001, Acute cigarette smoke exposure induces apoptosis of alveolar macrophages, Am. J. Physiol. Lung Cell Mol. Physiol., 281, L1392, 10.1152/ajplung.2001.281.6.L1392
Wang, 2001, The role of nitric oxide on cigarette smoke-induced programmed cell death in the gastric mucosa, Scand. J. Gastroenterol., 36, 235, 10.1080/003655201750074438
Rajpurkar, 2002, Cigarette smoking induces apoptosis in rat testis, J. Environ. Pathol. Toxicol. Oncol., 21, 243
Jiang, 1991, Endothelium-independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro, Br. J. Pharmacol., 104, 1033, 10.1111/j.1476-5381.1991.tb12545.x
Herrington, 1994, Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy, Am. J. Cardiol., 73, 951, 10.1016/0002-9149(94)90136-8
Bell, 1995, Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries, Am. J. Physiol., 268, H377
Volterrani, 1995, Estrogen acutely increases peripheral blood flow in postmenopausal women, Am. J. Med., 99, 119, 10.1016/S0002-9343(99)80130-2
Nematbakhsh, 2004, The effect of estrogen on serum nitric oxide concentrations in normotensive and DOCA Salt hypertensive ovariectomized rats, Clin. Chim. Acta, 344, 53, 10.1016/j.cccn.2004.01.019
Rosselli, 1995, Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study, Hypertension, 25, 848, 10.1161/01.HYP.25.4.848
Kleinert, 1998, Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved, Hypertension, 31, 582, 10.1161/01.HYP.31.2.582
Armour, 1998, Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells, Endocrinology, 139, 799, 10.1210/en.139.2.799
Caulin-Glaser, 1997, 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization, Circ. Res., 81, 885, 10.1161/01.RES.81.5.885
Knot, 1999, Gender differences in coronary artery diameter reflect changes in both endothelial Ca2+ and ecNOS activity, Am. J. Physiol., 276, H961
Hood, 1998, VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells, Am. J. Physiol., 274, H1054
Parenti, 1998, Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium, J. Biol. Chem., 273, 4220, 10.1074/jbc.273.7.4220
Ziche, 1997, Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis, J. Clin. Invest., 99, 2625, 10.1172/JCI119451
Khazaei, 2006, Serum level of vascular endothelial growth factor is increased by estrogen replacement therapy in normotensive and DOCA-Salt hypertensive ovariectomized rats, Clin. Chim. Acta, 365, 206, 10.1016/j.cca.2005.08.020
Dimmeler, 1997, Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide, Circ. Res., 81, 970, 10.1161/01.RES.81.6.970
Moien-Afshari, 2003, Long-term effects of ovariectomy and estrogen replacement treatment on endothelial function in mature rats, Maturitas, 45, 213, 10.1016/S0378-5122(03)00149-X
Matz, 2000, Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products, Physiol. Res., 49, 11
Best, 1998, The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women, Ann. Intern. Med., 128, 285, 10.7326/0003-4819-128-4-199802150-00006
Bassenge, 1994, Coronary vasomotor responses: role of endothelium and nitrovasodilators, Cardiovasc. Drugs Ther., 8, 601, 10.1007/BF00877414
Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321
Hulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group, JAMA, 280, 605, 10.1001/jama.280.7.605
Okon, 2003, Augmented contractile response of vascular smooth muscle in a diabetic mouse model, J. Vasc. Res., 40, 520, 10.1159/000075238
Lagaud, 2001, Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries, J. Vasc. Res., 38, 578, 10.1159/000051094
Yu, 2002, Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats, Cardiovasc. Res., 56, 303, 10.1016/S0008-6363(02)00513-8
Vlassara, 1992, Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications, Proc. Natl. Acad. Sci. U.S.A., 89, 12043, 10.1073/pnas.89.24.12043
Laight, 2000, Antioxidants, diabetes and endothelial dysfunction, Cardiovasc. Res., 47, 457, 10.1016/S0008-6363(00)00054-7
Hink, 2001, Mechanisms underlying endothelial dysfunction in diabetes mellitus, Circ. Res., 88, E14, 10.1161/01.RES.88.2.e14
Mutalik, 2004, Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations, J. Pharm. Sci., 93, 1577, 10.1002/jps.20058
Guo, 2001, Effects of age and food restriction on oxidative DNA damage and antioxidant enzyme activities in the mouse aorta, Mech. Ageing Dev., 122, 1771, 10.1016/S0047-6374(01)00298-6
De Angelis, 2004, Exercise training changes autonomic cardiovascular balance in mice, J. Appl. Physiol., 96, 2174, 10.1152/japplphysiol.00870.2003
Dimmeler, 2001, HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway, J. Clin. Invest., 108, 391, 10.1172/JCI200113152
Takahashi, 1999, Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nat. Med., 5, 434, 10.1038/8462
Konstantinides, 2001, The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity, Ann. NY Acad. Sci., 947, 134, 10.1111/j.1749-6632.2001.tb03936.x
Konstantinides, 2001, Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity, J. Clin. Invest., 108, 1533, 10.1172/JCI13143
Laufs, 2004, Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis, Circulation, 109, 220, 10.1161/01.CIR.0000109141.48980.37
Rehman, 2004, Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells, J. Am. Coll. Cardiol., 43, 2314, 10.1016/j.jacc.2004.02.049
Niebauer, 2003, NOS inhibition accelerates atherogenesis: reversal by exercise, Am. J. Physiol. Heart Circ. Physiol., 285, H535, 10.1152/ajpheart.00360.2001
Bagi, 2003, Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus, Am. J. Physiol. Heart Circ. Physiol., 285, H1404, 10.1152/ajpheart.00235.2003
Koltai, 1997, Characteristics of coronary endothelial dysfunction in experimental diabetes, Cardiovasc. Res., 34, 157, 10.1016/S0008-6363(97)00050-3
Khazaei, 2007, Effect of exercise on augmented aortic vasoconstriction in the db/db mouse model of type-II diabetes, Physiol. Res.
Elmi, 2007, Sulfaphenazole treatment restores endothelium-dependent vasodilation in diabetic mice, Vascul. Pharmacol.
Frisbee, 2002, Oxidant stress-induced increase in myogenic activation of skeletal muscle resistance arteries in obese Zucker rats, Am. J. Physiol. Heart Circ. Physiol., 283, H2160, 10.1152/ajpheart.00379.2002
Cosentino, 1997, High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells, Circulation, 96, 25, 10.1161/01.CIR.96.1.25
Wang, 2002, Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-beta activation in mesangial cells, J. Biol. Chem., 277, 9880, 10.1074/jbc.M108360200
Jensen, 1989, Features of endothelial dysfunction in early diabetic nephropathy, Lancet, 1, 461, 10.1016/S0140-6736(89)91365-2
Asahina, 1995, Impaired activation of glucose oxidation and NADPH supply in human endothelial cells exposed to H2O2 in high-glucose medium, Diabetes, 44, 520, 10.2337/diabetes.44.5.520
Kamata, 1995, Decreased Ca2+ influx into the endothelium contributes to the decrease in endothelium-dependent relaxation in the aorta of streptozotocin-induced diabetic mice, Res. Commun. Mol. Pathol. Pharmacol., 90, 69
Weisbrod, 1993, Effect of elevated glucose on cyclic GMP and eicosanoids produced by porcine aortic endothelium, Arterioscler. Thromb., 13, 915, 10.1161/01.ATV.13.6.915
Pieper, 1998, Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction, Hypertension, 31, 1047, 10.1161/01.HYP.31.5.1047
Tuck, 2003, Nitric oxide in diabetes mellitus, J. Hypertens., 21, 1081, 10.1097/00004872-200306000-00005
Pannirselvam, 2003, Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice, Br. J. Pharmacol., 140, 701, 10.1038/sj.bjp.0705476
Maejima, 2001, Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications, J. Diabetes Complications, 15, 135, 10.1016/S1056-8727(01)00144-1
Abebe, 1990, Protein kinase C-mediated contractile responses of arteries from diabetic rats, Br. J. Pharmacol., 101, 465, 10.1111/j.1476-5381.1990.tb12731.x
Tesfamariam, 1989, Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2, Am. J. Physiol., 257, H1327
Dong, 1992, Verapamil ameliorates the clinical and pathological course of murine myocarditis, J. Clin. Invest., 90, 2022, 10.1172/JCI116082
Yamada, 1992, The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis, Jpn. Circ. J., 56, 1138, 10.1253/jcj.56.1138
Rezkalla, 1990, Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis, Circulation, 81, 1039, 10.1161/01.CIR.81.3.1039
Ono, 1999, Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis: acute effects of bosentan, an endothelin receptor antagonist, Circulation, 100, 1823, 10.1161/01.CIR.100.17.1823
Choy, 2004, Coxsackievirus B3 infection compromises endothelial-dependent vasodilation of coronary resistance arteries, J. Cardiovasc. Pharmacol., 43, 39, 10.1097/00005344-200401000-00007
Lui, 2000, Endothelial and myogenic regulation of coronary artery tone in the mouse, Eur. J. Pharmacol., 410, 25, 10.1016/S0014-2999(00)00868-2
Klein, 1998, Evidence of endothelial dysfunction of epicardial coronary arteries in patients with immunohistochemically proven myocarditis, Am. Heart J., 136, 389, 10.1016/S0002-8703(98)70211-X
Treasure, 1990, Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy, Circulation, 81, 772, 10.1161/01.CIR.81.3.772
Wang, 2004, Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries, FASEB J., 18, 606, 10.1096/fj.03-0840fje
Koh, 2004, T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase, J. Clin. Invest., 114, 846, 10.1172/JCI21767
Hosenpud, 1998, The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report—1998, J. Heart Lung Transplant., 17, 656
Marti, 2001, Coronary endothelial dysfunction as a predictor of intimal thickening in the long term after heart transplantation, J. Thorac. Cardiovasc. Surg., 122, 1174, 10.1067/mtc.2001.117836
Hollenberg, 2001, Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death, Circulation, 104, 3091, 10.1161/hc5001.100796
Andriambeloson, 2001, Transplantation-induced endothelial dysfunction as studied in rat aorta allografts, Transplantation, 72, 1881, 10.1097/00007890-200112270-00004
Treasure, 1995, Relevance of vascular biology to the ischemc syndromes of coronary atherisclerosis, Cardiovasc. Drugs Ther., 9, 13, 10.1007/BF00878568
Day, 1995, Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury, J. Heart Lung Transplant., 14, S142
Libby, 1992, Immunopathology of coronary arteriosclerosis in transplanted hearts, J. Heart Lung Transplant., 11, S5
Skarsgard, 2000, Profound inhibition of myogenic tone in rat cardiac allografts is due to eNOS- and iNOS-based nitric oxide and an intrinsic defect in vascular smooth muscle contraction, Circulation, 101, 1303, 10.1161/01.CIR.101.11.1303
Moien-Afshari, 2004, Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts, J. Heart Lung Transplant., 23, 193, 10.1016/S1053-2498(03)00113-X
Dong, 1996, Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy, Lab. Invest., 74, 921
Choy, 2004, Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts, Am. J. Pathol., 165, 127, 10.1016/S0002-9440(10)63281-6
Lai, 2003, Ultrastructural evidence of early endothelial damage in coronary arteries of rat cardiac allografts, J. Heart Lung Transplant., 22, 993, 10.1016/S1053-2498(02)01163-4